Related Experiment Video
Updated: Oct 22, 2025

07:43
Endoscopic Endonasal Trans-sphenoidal Approach: Minimally Invasive Surgery for Pituitary Adenomas
Published on: January 17, 2018
19.1K
Primary hyperparathyroidism causing posterior reversible encephalopathy syndrome: a case report.
Annals of the Royal College of Surgeons of England
|August 27, 2021
Summary
Posterior reversible encephalopathy syndrome (PRES) is a rare neurological condition. This case highlights a patient with severe hyperparathyroidism who developed PRES, with symptoms resolving after parathyroidectomy.
Area of Science:
- Neurology
- Endocrinology
- Radiology
Background:
- Posterior reversible encephalopathy syndrome (PRES) is a neurological condition characterized by vasogenic edema and neurological deficits.
- Primary hyperparathyroidism is a condition involving overactive parathyroid glands, leading to elevated parathyroid hormone (PTH) and calcium levels.
- PRES is typically associated with hypertension, immunosuppression, and renal failure, but can occur in other contexts.
Observation:
- A 64-year-old woman with symptomatic primary hyperparathyroidism (PTH 1,330 ng/L, calcium 4.83 mmol/L) presented with intractable seizures.
- Brain MRI revealed bilateral symmetrical T2 hyperintensities in the posterior circulation, indicative of PRES.
- A parathyroid adenoma was identified via Technetium-99m sestamibi scan.
Findings:
- The patient underwent parathyroidectomy, with preoperative and postoperative PTH levels of 1,021 ng/L and 10 ng/L, respectively.
- Neurological symptoms resolved, and the patient was extubated on postoperative day 1, making an uneventful recovery.
- All neurological symptoms resolved by the 6-week follow-up appointment.
Implications:
- This case underscores that PRES can manifest in patients with severe hyperparathyroidism, even without typical risk factors.
- Early recognition and management of hyperparathyroidism may be crucial in preventing or resolving PRES.
- The findings suggest that severe hypercalcemia secondary to hyperparathyroidism could be an underrecognized trigger for PRES.

